Asuragen, Inc. Release: Asuragen, Inc. Researchers Publish Results of Study Evaluating Multiplex Assay for Detection of Common NPM1 Mutations
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today the results of a collaborative study with scientists at Johns Hopkins University School of Medicine evaluating a RNA-based assay for the rapid, sensitive and multiplex detection of common NPM1 mutations. The study results were published in the September issue of the Journal of Molecular Diagnostics.